<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma"</p><p>http://www.biomedcentral.com/1471-2407/7/125</p><p>BMC Cancer 2007;7():125-125.</p><p>Published online 8 Jul 2007</p><p>PMCID:PMC1931603.</p><p></p> Means that are significantly different from the control group are indicated with an asterisk (< 0.05)
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...
<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin...
<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin...
<p><b>Copyright information:</b></p><p>Taken from "Role of the p53/p21 system in the response of hum...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>A-F) The line graph shows the cell viability (%) in MDA-MB-231 cells stably expressing NT or shAB...
<p>SGC-996 cells were treated with or without different concentrations of TSA or SAHA for 24 h. The ...
<p><b>Copyright information:</b></p><p>Taken from "Anticlusterin treatment of breast cancer cells in...
Corporation and 7-AAD. Data indicate the percentage of cells in each phase of cell cycle. Results ar...
<p><b>Copyright information:</b></p><p>Taken from "Anticlusterin treatment of breast cancer cells in...
Background: Poor prognosis in gallbladder cancer is due to late presentation of the disease, lack of...
Top panel: BRCA1-defective UM-SSC-17B cells [6] were mock treated for 5 days (control), treated with...
Gallbladder cancer, with high aggressivity and extremely poor prognosis, is the most common malignan...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...
<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin...
<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin...
<p><b>Copyright information:</b></p><p>Taken from "Role of the p53/p21 system in the response of hum...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>A-F) The line graph shows the cell viability (%) in MDA-MB-231 cells stably expressing NT or shAB...
<p>SGC-996 cells were treated with or without different concentrations of TSA or SAHA for 24 h. The ...
<p><b>Copyright information:</b></p><p>Taken from "Anticlusterin treatment of breast cancer cells in...
Corporation and 7-AAD. Data indicate the percentage of cells in each phase of cell cycle. Results ar...
<p><b>Copyright information:</b></p><p>Taken from "Anticlusterin treatment of breast cancer cells in...
Background: Poor prognosis in gallbladder cancer is due to late presentation of the disease, lack of...
Top panel: BRCA1-defective UM-SSC-17B cells [6] were mock treated for 5 days (control), treated with...
Gallbladder cancer, with high aggressivity and extremely poor prognosis, is the most common malignan...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...
<p><b>Copyright information:</b></p><p>Taken from "Human agonistic TRAIL receptor antibodies Mapatum...